UBS analyst Jon Windham lowered the firm’s price target on WM (WM) to $225 from $240 and keeps a Neutral rating on the shares. The price target has been adjusted to reflect concerns on WM Healthcare Solutions’ customer retention, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WM: